2nd Real-World Evidence Forum – 2nd Real-World Evidence Forum

Real-world evidence can provide key insights that will help drive down medical costs, as well as improve both product safety and effectiveness. Unfortunately, the relevance and validity of user-collected and practiced based real-world data is a challenge within the clinical health industry. If real-world data isn’t properly analyzed it can be tricky to utilize successfully. Companies must have an in-depth understanding of the data landscape and how to assess real-world data sources, analytics and applications to build real-world data platforms.

Proving safety and effectiveness through a randomized clinical trial no longer secure success and profitability of a drug or device. Companies must now demonstrate evidence of successful real-world outcomes to distinguish their products in an aggressive environment. While also fulfilling requests from regulators, insurance companies, healthcare providers, and patients.

The Real-World Evidence Forum, taking place on July 16-17, 2018 in Philadelphia, will bring together clinical health professionals to address how to operationalize the process of collecting real-world data. Our expert staff will discuss how to utilize real-world evidence to demonstrate both clinical effectiveness and cost-effectiveness of your product. Attendees will gain a better understanding of how electronic data sources are changing the way real-world data is being collected. This conference will offer attendees insight on how real-world evidence will help decrease costs and development timelines, define innovative outcomes, and minimize the number of patients exposed to less useful medications.

Featured Session

Interpret FDA Guidance: How the Agency May Use Data to Support Regulatory Decision-Making

Nneka Onwudiwe, Pharm.D., Ph.D., MBA,
PRO/PE Regulatory Review Officer,
FOOD AND DRUG ADMINISTRATION

Advance Healthcare Innovation Using Real-World Evidence

Christopher Boone, Ph.D., FACHE,
Vice President, Real-World Data and Analytics Center of Excellence, Patient and Health Impact,
PFIZER,

Understand the Role of RWE in Driving Healthcare Reform and Decision-Making

Melinda Hanisch,
Director, Research Dissemination, Real-World Evidence and Global Market Access Policy Expert,
MERCK

Top Five Reasons to Attend

  1. Discuss how the industry is transforming the drug development process through the use of real-world evidence
  2. Learn to operationalize the process of collecting real-world data
  3. Utilize real-world evidence to demonstrate both clinical effectiveness and cost-effectiveness of your product
  4. Discover how electronic data sources are changing the way real-world data is being composed
  5. Examine the need for greater data sharing practices and transparency of methods when used for regulatory decision-making

Who Should Attend

This conference is designed for professionals from pharmaceutical companies with responsibilities in the following areas:

  • Real-World Evidence
  • Phase IV
  • Post Market Surveillance
  • Late Phase
  • Medical Affairs
  • Data Management
  • Project Management
  • Business Development
  • Clinical Development
  • Global Medical Affairs
  • Observational Research
  • HEOR / GHEOR
  • Patient Safety Surveillance
  • Clinical Trial Design and Management
  • Data Management Operational Support
  • Regulatory Affairs
  • Registry
  • Drug Safety
  • Patient-Reported Outcomes
  • Post-Approval

This event is also of interest to:

  • CROs
  • Clinical Trial Management Software Providers
  • Big Data Platforms
Startdate: 2018-07-17
End Date 2018-07-18

Description: The Real-World Evidence Forum will provide in-depth industry knowledge on operationalizing the use of real-world data.
Performer:
Address : 2nd Real-World Evidence Forum